BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

BioTie Therapies Corp. 

Tykistokatu 6

Turku    FIN-20520  Finland
Phone: 358-2-274-8900 Fax: 358-2-274-8910


SEARCH JOBS








 Company News
BioTie Therapies Corp. Announces Start of Clinical Study With Nepicastat (SYN117) in Cocaine Dependence 5/10/2013 10:59:53 AM    More...
BioTie Therapies Corp.: Selincro Launched in the United Kingdom 5/6/2013 11:10:34 AM    More...
Change in the Number of Votes Relating to BioTie Therapies Corp.'s Shares 5/6/2013 9:54:54 AM    More...
BioTie Therapies Corp.: Selincro Launched in the United Kingdom 5/6/2013 9:31:47 AM    More...
BioTie Therapies Corp.: Selincro Launched in First European Markets 4/22/2013 12:14:36 PM    More...
Resolutions of the Annual General Meeting of BioTie Therapies Corp. and Organization of the Board 4/4/2013 11:42:57 AM    More...
BioTie Therapies Corp. Presents Tozadenant Phase 2b Data at American Academy of Neurology Annual Meeting 3/21/2013 9:51:03 AM    More...
BioTie Therapies Corp.: Selincro (nalmefene) Receives European Marketing Authorization 2/28/2013 9:15:36 AM    More...
UCB, Inc. (UCBJF.PK) Licenses Global Rights to Tozadenant in Parkinson's Disease From BioTie Therapies Corp. for $20 Million 2/27/2013 7:14:28 AM    More...
BioTie Therapies Corp. Reports Top-Line Data From Clinical Study With Nepicastat (SYN117) in Post-Traumatic Stress Disorder 12/27/2012 8:52:30 AM    More...
12345678